{
    "title": "RSS Feed Title",
    "link": "https://example.com",
    "description": "RSS Feed Description",
    "lastBuildDate": "2025-05-20T17:31:56.891812",
    "items": [
        {
            "title": "Ixigo \u2013 What next after a blockbuster quarter?",
            "link": "https://www.moneycontrol.com/news/business/earnings/ixigo-what-next-after-a-blockbuster-quarter-13033719.html",
            "description": "Travel market growth, customer stickiness and value-added offerings augur well for the company",
            "pubDate": "2025-05-20T04:31:44.670974"
        },
        {
            "title": "Chart of the Day: BHEL\u2019s record order book faces a moment of reckoning",
            "link": "https://www.moneycontrol.com/news/opinion/chart-of-the-day-bhel-s-record-order-book-faces-a-moment-of-reckoning-13033452.html",
            "description": "The company saw record order inflows for second consecutive year in FY25",
            "pubDate": "2025-05-20T04:31:44.671067"
        },
        {
            "title": "ITC Hotels: Strong Q4; robust growth outlook",
            "link": "https://www.moneycontrol.com/news/business/stocks/itc-hotels-strong-q4-robust-growth-outlook-13033936.html",
            "description": "ITC Hotels has a healthy inventory addition pipeline and there is scope for further sweating the current asset portfolio",
            "pubDate": "2025-05-20T05:14:13.744292"
        },
        {
            "title": "Zydus Lifesciences Q4 net profit rises 18% on strong US, India sales",
            "link": "https://www.moneycontrol.com/news/business/earnings/zydus-lifesciences-q4-net-profit-rises-18-on-strong-us-india-sales-13035154.html",
            "description": "Consolidated revenue from operations rose 18% YoY  to Rs 6528 crore, while EBITDA surged 30% to Rs 2,126 crore, with margins expanding 310 basis points to 32.6%.",
            "pubDate": "2025-05-20T10:59:39.879219"
        },
        {
            "title": "Zydus targets FY26 expansion, but warns of slower US momentum post-Revlimid peak",
            "link": "https://www.moneycontrol.com/news/business/companies/zydus-targets-fy26-expansion-but-warns-of-slower-us-momentum-post-revlimid-peak-13035801.html",
            "description": "The US business, a significant contributor to its revenue, is projected for single-digit growth in FY26.",
            "pubDate": "2025-05-20T15:56:31.695021"
        },
        {
            "title": "UGRO Capital board okays Rs 1,314 cr fund raise via rights issue, unsecured compulsorily convertible debentures",
            "link": "https://www.moneycontrol.com/news/business/companies/ugro-capital-board-okays-rs-1-314-cr-fund-raise-via-rights-issue-unsecured-compulsorily-convertible-debentures-13035820.html",
            "description": "The board has also approved to increase authorized share capital to Rs 270 crore, from Rs 215 crore",
            "pubDate": "2025-05-20T15:56:31.695096"
        },
        {
            "title": "Max Healthcare Q4FY25 net profit rises 21% on higher patient volumes; expansion plans in focus",
            "link": "https://www.moneycontrol.com/news/business/earnings/max-healthcare-q4fy25-net-profit-rises-21-on-higher-patient-volumes-expansion-plans-in-focus-13035553.html",
            "description": "The company announced strategic expansion initiatives to bolster its pan-India presence including plans to add 1,500 beds in FY26 through brownfield expansions at Saket, Nanavati, and Mohali hospitals.",
            "pubDate": "2025-05-20T15:56:31.695162"
        },
        {
            "title": "IHH\u2019s NTK ups damages claim against Daiichi Sankyo to Rs 11,800 crore in Fortis deal dispute",
            "link": "https://www.moneycontrol.com/news/business/companies/ihh-s-ntk-ups-damages-claim-against-daiichi-sankyo-to-rs-11-800-crore-in-fortis-deal-dispute-13035539.html",
            "description": "The revised claim stems from NTK\u2019s allegations that Daiichi Sankyo obstructed its 2018 open offer to acquire shares in India\u2019s Fortis Healthcare and its subsidiary Fortis Malar Hospitals.",
            "pubDate": "2025-05-20T15:56:31.695227"
        },
        {
            "title": "Aster DM Healthcare Q4 net profit jumps 21% on margin gains; merger with Quality Care advances",
            "link": "https://www.moneycontrol.com/news/business/earnings/aster-dm-healthcare-q4-net-profit-jumps-21-on-margin-gains-merger-with-quality-care-advances-13035893.html",
            "description": "Revenue for Q4 FY25 rose 2% YoY to Rs 1,000 crore, while operating EBITDA grew 16% to Rs 193 crore.",
            "pubDate": "2025-05-20T17:31:55.738938"
        },
        {
            "title": "Gland Pharma Q4 net profit slips 3% as US sales moderate; focus shifts to complex injectables, CDMO growth",
            "link": "https://www.moneycontrol.com/news/business/earnings/gland-pharma-q4-net-profit-slips-3-as-us-sales-moderate-focus-shifts-to-complex-injectables-cdmo-growth-13035853.html",
            "description": "\u201cFY25 was a year of strategic realignment and investment in future growth,\u201d said Executive Chairman Srinivas Sadu.",
            "pubDate": "2025-05-20T17:31:55.739025"
        }
    ]
}